13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 36 holding rows worth $237,906,000.
- Accession
- 0001104659-22-021652
- Filer
- CIK 1582844
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 36 entries on the cover page, a total value of $237,906,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $237,906,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,529,402 | $36,935,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 535,000 | $25,295,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 11,736,283 | $22,886,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 340,098 | $13,141,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 419,632 | $9,790,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 404,000 | $9,102,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 843,122 | $8,263,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 470,000 | $7,858,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 235,500 | $7,489,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 677,753 | $7,435,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 225,000 | $7,029,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 105,500 | $6,995,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 318,000 | $6,287,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 562,500 | $5,496,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS PLC | 999222ZZ8 | SPONSORED ADR | 580,000 | $4,686,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 206,126 | $4,512,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 391,974 | $4,457,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 525,000 | $4,226,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 291,884 | $4,086,000 | thousands by filing date | |
| SEELOS THERAPEUTICS INC | 81577F109 | COM | 2,500,000 | $4,075,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 310,030 | $4,040,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 392,500 | $3,956,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 1,865,000 | $3,823,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 200,000 | $3,538,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 179,995 | $3,436,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 230,000 | $3,186,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 243,072 | $2,975,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 20,000 | $2,934,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 500,000 | $2,000,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 68,500 | $1,489,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 98,000 | $1,425,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 119,843 | $1,355,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 322,500 | $1,264,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 262,500 | $1,205,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 127,500 | $1,065,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 90,832 | $172,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-021652 | this filing | 2022-02-14 | acceptance time not in the bulk data set |